Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

The GLP-1 telehealth market got a lot messier in 2026, and the names people actually trust got easier to spot. Here is why that matters. A wave of FDA warning letters hit 30-plus compounders early in 2026, and a settlement…